loading
Abrdn Life Sciences Investors stock is traded at $13.83, with a volume of 83,265. It is down -1.57% in the last 24 hours and up +3.98% over the past month. abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$14.05
Open:
$13.78
24h Volume:
83,265
Relative Volume:
0.79
Market Cap:
$399.31M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.22%
1M Performance:
+3.98%
6M Performance:
-0.14%
1Y Performance:
-11.69%
1-Day Range:
Value
$13.71
$13.95
1-Week Range:
Value
$13.71
$14.10
52-Week Range:
Value
$10.55
$15.68

Abrdn Life Sciences Investors Stock (HQL) Company Profile

Name
Name
Abrdn Life Sciences Investors
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-08-06
Name
Latest SEC Filings
Name
HQL's Discussions on Twitter

Compare HQL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Closed-End Fund - Equity icon
HQL
Abrdn Life Sciences Investors
13.83 403.64M 0 0 0 0.00
Closed-End Fund - Equity icon
DNP
Dnp Select Income Fund Inc
9.87 3.66B 0 0 0 0.00
Closed-End Fund - Equity icon
UTG
Reaves Utility Income Fund
37.78 3.40B 0 0 0 0.00
Closed-End Fund - Equity icon
UTF
Cohen Steers Infrastructure Fund Inc
27.06 2.58B 0 0 0 0.00
Closed-End Fund - Equity icon
ADX
Adams Diversified Equity Fund
21.65 2.62B 0 0 0 0.00
Closed-End Fund - Equity icon
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
15.71 2.47B 0 0 0 0.00

Abrdn Life Sciences Investors Stock (HQL) Latest News

pulisher
Aug 20, 2025

Watch for Bullish Crossover in Abrdn Life Sciences InvestorsWeekly Loss Report & Trade Opportunity Analysis - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

How to use Fibonacci retracement on Abrdn Healthcare InvestorsMarket Weekly Review & Target Return Focused Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How sentiment analysis helps forecast Abrdn Life Sciences InvestorsWeekly Loss Report & Weekly Breakout Stock Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What the charts say about Abrdn Life Sciences Investors todayJuly 2025 Catalysts & Safe Capital Investment Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Smart tools for monitoring Abrdn Life Sciences Investors’s price actionGlobal Markets & Risk Controlled Daily Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What momentum shifts mean for Abrdn Healthcare Investors2025 Risk Factors & Trade Opportunity Analysis Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-20 01:13:33 - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to manage a losing position in Abrdn Life Sciences Investors2025 Sector Review & AI Based Buy/Sell Signal Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using portfolio simulators with Abrdn Life Sciences Investors includedMarket Growth Summary & Scalable Portfolio Growth Methods - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Sentiment analysis tools applied to Abrdn Life Sciences InvestorsJuly 2025 Rallies & Real-Time Volume Analysis - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Exit strategy if you’re trapped in Abrdn Healthcare Investors2025 Institutional Moves & Long Hold Capital Preservation Plans - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Risk adjusted return profile for Abrdn Life Sciences Investors analyzedDay Trade & Stepwise Swing Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Identifying reversal signals in Abrdn Life Sciences Investors2025 Volume Leaders & Community Consensus Trade Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 17:21:45 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Key resistance and support levels for Abrdn Healthcare InvestorsJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

US Bancorp DE Has $61,000 Holdings in abrdn Healthcare Investors $HQH - Defense World

Aug 19, 2025
pulisher
Aug 19, 2025

LPL Financial LLC Has $4.17 Million Stake in abrdn Life Sciences Investors $HQL - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

abrdn Life Sciences Investors (NYSE:HQL) Sees Significant Drop in Short Interest - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Can a trend reversal in Abrdn Life Sciences Investors lead to recoveryWeekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Abrdn Life Sciences Investors Charts Flash Early Recovery SignalsPortfolio Growth Summary & Advanced Technical Signal Analysis - beatles.ru

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 07:09:05 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 06:18:48 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What high frequency data says about Abrdn Healthcare Investors2025 Big Picture & High Conviction Buy Zone Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can Abrdn Life Sciences Investors recover in the next quarter2025 Retail Activity & AI Forecasted Stock Moves - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 04:39:05 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - ADVFN Brasil

Aug 19, 2025
pulisher
Aug 19, 2025

What MACD signals say about Abrdn Life Sciences InvestorsJuly 2025 Levels & Weekly High Return Opportunities - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Dividend Information for Abrdn Life Sciences Investors: Key Insights Before the Ex-Dividend Date on Aug 22, 2025 - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Volume Profile Shows Strong Base for Abrdn Healthcare InvestorsWeekly Gains Report & Long-Term Safe Return Strategies - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

abrdn Life Sciences Investors (NYSE:HQL) Declares Quarterly Dividend of $0.42 - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Why Abrdn Healthcare Investors is moving todayMarket Risk Report & Reliable Intraday Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Building trade automation scripts for Abrdn Life Sciences InvestorsPortfolio Gains Report & Comprehensive Market Scan Reports - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Using AI based signals to follow Abrdn Healthcare Investors2025 Market Trends & Community Supported Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Abrdn Healthcare Investors stock momentum explained2025 Price Targets & Weekly High Return Stock Opportunities - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 22:00:16 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Applying big data sentiment scoring on Abrdn Life Sciences InvestorsTrade Entry Summary & Long Hold Capital Preservation Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Abrdn Healthcare Investors Rebound Backed by Sentiment ShiftBear Alert & Free Long-Term Investment Growth Plans - 선데이타임즈

Aug 17, 2025
pulisher
Aug 17, 2025

Is Abrdn Healthcare Investors stock poised for growthProfit Target & AI Based Trade Execution Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Abrdn Healthcare Investors trending in predictive chart models2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Abrdn Healthcare Investors meeting your algorithmic filter criteria2025 Year in Review & Real-Time Stock Price Movement Reports - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Abrdn Life Sciences Investors see short term momentumStop Loss & High Accuracy Trade Signal Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 03:54:00 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Comparing Abrdn Life Sciences Investors in custom built stock radarsWeekly Volume Report & Risk Managed Investment Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Why Abrdn Life Sciences Investors stock attracts strong analyst attentionJuly 2025 Analyst Calls & Weekly High Momentum Picks - Newser

Aug 17, 2025

Abrdn Life Sciences Investors Stock (HQL) Financials Data

There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
closed_end_fund_equity RVT
$15.92
price up icon 2.84%
closed_end_fund_equity GAB
$6.00
price up icon 1.01%
closed_end_fund_equity CLM
$8.09
price up icon 0.75%
closed_end_fund_equity KYN
$12.32
price up icon 0.33%
closed_end_fund_equity GDV
$26.75
price up icon 1.17%
closed_end_fund_equity ETY
$15.71
price up icon 0.96%
Cap:     |  Volume (24h):